Cargando…

Genome-wide profiling reveals transcriptional repression of MYC as a core component of NR4A tumor suppression in acute myeloid leukemia

Acute myeloid leukemias (AMLs) are a heterogeneous group of diseases that are sustained by relatively rare leukemia-initiating cells (LICs) that exhibit diverse genetic and phenotypic properties. AML heterogeneity presents a major challenge to development of targeted therapies, and effective treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boudreaux, S P, Ramirez-Herrick, A M, Duren, R P, Conneely, O M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412651/ https://www.ncbi.nlm.nih.gov/pubmed/23552735 http://dx.doi.org/10.1038/oncsis.2012.19

Ejemplares similares

Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells
por: Duren, Ryan P., et al.
Publicado: (2016)

Drug Targeting of NR4A Nuclear Receptors for Treatment of Acute Myeloid Leukemia
por: Boudreaux, Seth P., et al.
Publicado: (2018)

Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors
por: Call, S. Greg, et al.
Publicado: (2020)

Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia
por: Sodaro, Gaetano, et al.
Publicado: (2017)

Role of NR4A family members in myeloid cells and leukemia
por: Boulet, Salix, et al.
Publicado: (2022)

Matrine, a potential c-Myc inhibitor, suppresses ribosome biogenesis and nucleotide metabolism in myeloid leukemia
por: Zhong, Wang-Jing, et al.
Publicado: (2022)

Direct and indirect targeting of MYC to treat acute myeloid leukemia
por: Brondfield, Sam, et al.
Publicado: (2015)

MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences
por: L′Abbate, Alberto, et al.
Publicado: (2018)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences
por: L’Abbate, Alberto, et al.
Publicado: (2018)

The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
por: Pippa, Raffaella, et al.
Publicado: (2020)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Genome-wide identification and characterization of polycomb repressive complex 2 core components in upland cotton (Gossypium hirsutum L.)
por: Cheng, Kai, et al.
Publicado: (2023)

Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy
por: Conneely, Shannon E., et al.
Publicado: (2021)

The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
por: Ge, Ying, et al.
Publicado: (2019)

c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia
por: Su, Rui, et al.
Publicado: (2016)

Structural basis of JAZ repression of MYC transcription factors in jasmonate signaling
por: Zhang, Feng, et al.
Publicado: (2015)

Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
por: Li, Gong-Quan, et al.
Publicado: (2015)

Meiotic gatekeeper STRA8 suppresses autophagy by repressing Nr1d1 expression during spermatogenesis in mice
por: Ferder, Ianina C., et al.
Publicado: (2019)

Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
por: Reynolds, Christine, et al.
Publicado: (2014)

Regulation of the somatotropic axis by MYC-mediated miRNA repression
por: Petrashen, Anna P., et al.
Publicado: (2023)

Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias
por: Nishida, Yuki, et al.
Publicado: (2023)

Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia
por: Zhou, Hao, et al.
Publicado: (2021)

BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
por: Hurtz, Christian, et al.
Publicado: (2011)

Transcriptional repression of Myc underlies the tumour suppressor function of AGO1 in Drosophila
por: Zaytseva, Olga, et al.
Publicado: (2020)

Depletion of polycomb repressive complex 2 core component EED impairs fetal hematopoiesis
por: Yu, Wenhua, et al.
Publicado: (2017)

Identification of polycomb repressive complex 1 and 2 core components in hexaploid bread wheat
por: Strejčková, Beáta, et al.
Publicado: (2020)

Therapy-related core binding factor acute myeloid leukemia
por: George, Binsah, et al.
Publicado: (2023)

circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex
por: Xie, Fei, et al.
Publicado: (2020)

Genome-wide binding of transcription factors in inv(16) acute myeloid leukemia
por: Mandoli, A., et al.
Publicado: (2014)

Antileukemic activity of YPN-005, a CDK7 inhibitor, inducing apoptosis through c-MYC and FLT3 suppression in acute myeloid leukemia
por: Koo, Bon-Kwan, et al.
Publicado: (2022)

Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development
por: Vishwakarma, Bandana A., et al.
Publicado: (2015)

MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression
por: Kim, Taewan, et al.
Publicado: (2015)

A Combinatorial Code for CPEB-Mediated c-myc Repression
por: Ogami, Koichi, et al.
Publicado: (2023)

Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a
por: Shields, Benjamin J., et al.
Publicado: (2016)

Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
por: Pan, Xiao-Na, et al.
Publicado: (2014)

MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia
por: Zhang, Xiaolu, et al.
Publicado: (2017)

Association between the CEBPA and c-MYC genes expression levels and acute myeloid leukemia pathogenesis and development
por: Krygier, Adrian, et al.
Publicado: (2020)

Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia
por: Mosna, Federico, et al.
Publicado: (2016)

SNP-array lesions in core binding factor acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5f15ajt7p0ooi3uh796bsd6ncb